Sanjiv Gangaram-Panday, PhD, discusses findings from a population-based cohort study of definitive chemoradiotherapy in esophageal adenocarcinoma.
Sanjiv Gangaram-Panday, PhD
Advertisement
Sanjiv Gangaram-Panday, PhD,of Erasmus University Rotterdam
Articles by Sanjiv Gangaram-Panday, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Sacituzumab Govitecan Approved in Europe for First-Line PD-L1 Inhibitor–Ineligible TNBC
2
Sigvotatug Vedotin Fails to Improve OS in Advanced, Pretreated Nonsquamous NSCLC
3
Allogeneic BCMA CAR T-Cell Therapy CT0596 Elicits 100% ORR in R/R Myeloma and Plasma Cell Leukemia
4
NCCN Includes PCR ctDNA-MRD Testing in MIBC Treatment Algorithm
5